A monoclonal antibody monospecific for human type IV collagen was used as a structural probe to examine aspects of the macromolecular organization of basementmembrane collagen. Electron-microscopic observation of rotary-shadowed antigenantibody complexes demonstrated a unique binding site for the antibody 55+6 nm distant from the 7S cross-linking region of tetrameric type IV collagen. This observation allowed a series of studies that showed: (1) the localization of an intramolecular disulphide bridge within the helical domain of the molecule, (2) the alignment of major peptic-digest fragments of the axl (IV) chain, and (3) confirmation of the postulated antiparallel arrangement collagen tetramers.
Type IV (basement-membrane) collagen is an unusual and uniquely specialized member of the collagen family of proteins. In addition to its distribution being sharply delimited to basement membranes, the molecular structure and supramolecular organization of type IV collagen differ in many respects to those of the interstitial types I, II and III collagens . The molecules of the latter are relatively rigid rods with a continuous 300nm-long triple helix. The more flexible threadlike molecules of basement-membrane collagen are about 400nm long and their triple helix is frequently interrupted by short non-helical regions (Schuppan et al., 1980; Glanville & Rauter, 1981; Oberbaumer et al., 1982) . Whereas collagen I, II and III molecules assemble in a parallel staggered array of similar polarity to form fibrils, type IV of individual molecules within type IV collagen molecules aggregate at their ends to form tetramers. The distal end of each arm of these tetramers terminates in a globular domain that interacts with the equivalent region of adjacent tetramers. This interaction provides the sites whereby tetrameric units are covalently crosslinked into a regular flexible network Duncan et al., 1983) .
Structural investigations of type IV collagen have typically been initiated by solubilizing tissues with pepsin (Dixit & Glanville, 1982) . Although the triple-helical domain of the molecule is resistant to proteolysis, the occurrence of multiple short non-helical regions susceptible to various extents to scission results in the generation of a family of proteolytic fragments, the sizes of which depend on the extent of digestion. Electronmicroscopic observations have demonstrated that pepsin initially digests the C-terminal globular domain. This leads to soluble tetrameric collagen containing four almost intact molecules bound together via their N-terminal 30nm-long triplehelical regions, which form the 7S domains . Next, the triple-helical region is attacked and two major triple-helical fragments with lengths of 330 and 267nm are set free . Denaturation and reduction of this material result in the release of a small proportion of a-chain fragments with M, values of Vol. 227 H. Dieringer and others 140000 and 70000. If the former material is reduced under native conditions and treated a second time with pepsin, the 140000-M, component is converted into a 95 000-Mr fragment (Glanville & Rauter, 1981) as the major product. Such proteolytic fragments are the starting materials for amino acid sequencing studies, and therefore the alignment of these peptides within the intact molecule is of considerable interest. Also, the localization of important features, such as intramolecular disulphide bridges, in the molecule, and the orientation of individual molecules in tetrameric type IV collagen, are desirable structural goals.
A preliminary account of part of this work has already been presented (Hollister et al., 1983) .
Methods

Preparation of type IV collagen and CNBr-cleavage peptides
Tetrameric collagen IV was solubilized by treating human placenta, suspended in 0.5Mformic acid, with pepsin (Boehringer, Mannheim) at 4°C for 6h and purified as described previously . Isolation of fragments al(IV)140K and al(IV)95K has been published previously (Dixit & Glanville, 1982) .
A trimeric disulphide-bridged fragment was prepared by cleaving unreduced tetrameric type IV collagen with CNBr and separating the peptide mixture by chromatography on agarose 1.5 m. The cysteine-containing CNBr-cleavage fragment was eluted in a peak with an Mr of approx. 90000. This fraction, when reduced, aminoethylated and rechromatographed on agarose 1.5 m, resolved into two main peaks containing peptides designated 'CB1' and 'CB1-2'. These peptides were further purified on phosphocellulose equilibrated with 0.55M-NaCl/2M-urea at pH3.9 and 45°C with a superimposed gradient of 0-0.5M-NaCl in a volume.,of 5OUkml. Construction of monoclonal antibody to human type IV collagen Monoclonal antibody topqpsin-solubilized type IV collagen derived from human foetal membranes was constructed by using SJL/J mice, and characterized as described by Sakai et al. (1982) . By solidphase. radioimmunoassay, this. antibody binrds native, but not denatured, human type IV collagen and exhibits no detectable cross-reactivity with native human collagen types I, II, III, V and native materials containing the la-, 2a-and 3a-chains. The antibody reacts with human type IV collagen but not type IV collagen from a variety of other mammalian species. As a control, the previously described hybridoma anti-body monospecific for pepsin-solubilized native human type II collagen was used. The binding of both antibodies to their respective target antigens was inhibited completely by prior specific collagenase digestion and/or prior heat denaturation, suggesting that both antibodies are directed against collagenous epitopes in or near the helical domains. In addition, isotyping indicated that both antibodies were of the IgG(2b) subclass. Before use and as the final purification step, both antibodies were affinity-purified on antigen-agarose columns.
Preparation of antigen-antibody complexes
To prepare antigen-antibody complexes, tetrameric type IV collagen and monoclonal antibody [either anti-(type IV) or anti-(type II)] were dissolved in 0.2M-NH4HCO3 and mixed to give an approximate molar ratio of antibody to antigen of 1: I and a final concentration of tetrameric type IV collagen of 50g/ml. This mixture was incubated at 4°C overnight.
Electron-microscopic observation of complexes
Protein samples were mixed with an equal volume of 70% (v/v) glycerol immediately before spraying on to freshly cleaved mica discs. An electron-bombarded source (Edward's) was used for shadowing the proteins with platinum at an angle of 9-10°, followed by carbon coating at 900, and the resultant specimens were examined in the electron microscope as previously described . Electron micrographs at 10000-30000 x magnification were prepared. Length measurements were performed by using a Numonic electronic graphic calculator on micrographs at a total magnification of 10000-15000 x and using the previously determined length of 30 nm for the central portion of human 7 S domain (30 nm) as an internal length standard .
Immunological techniques
The specificity of antibody binding to tetrameric type IV collagen and derived fragments was assayed by using an e.l.i.s.a. technique (Gosslau & Barrach, 1979; Rttmarde-i., et &I S i assays were performed by preincubation of antibody with inhibitor before e.l.i.s.a. assay on type IV collagen-coated plates.
Results
Affinity-purified monoclonal anti-(human type IV collagen) antibodywas found to bind with sufficient affinity to human tetrameric type IV collagen such that antigen-antibody complexes could be revealed by rotary-shadowing techniques. Electron micrographs of type IV collagen-antibody complexes (a) A tetrameric type IV collagen 'spider' complexed with monoclonal antibody is depicted. Note the symmetric and equidistant binding of antibody to adjacent arms of the spider. The globular profile indicated by a single arrow may represent an antibody molecule, or, more probably, represents a terminal globular NCl domain of the molecule that has survived proteolytic removal. (b) 'Spiders' of tetrameric type IV collagen complexed with antibody. The arrowheads denote the 7S cross-linking regions. Note the apparent 'cross-linking' of two adjacent arms of the spiders by bivalent antibody (double arrow) and the symmetrical distribution of antibody (single arrow) with respect to the 7S domain.
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Under identical conditions, affinity-purified monoclonal anti-(human type II collagen) antibody (of the same IgG(2b) isotype) did not bind to tetrameric type IV collagen. Fig. 1 demonstrates representative profiles obtained. In addition to the previously described linear replicas of tetrameric type IV collagen 'spiders', discrete globular (and occasionally somewhat triangular) profiles approx. 15nm in diameter are observed. These globular profiles, in numerous instances, appear in close association with and/or overlay the arms of the 'spider'; in other instances, such profiles are distant and distinct from the collagenous profile.
Control experiments with tetrameric type IV collagen alone or antibody alone demonstrated that the profiles observed in the mixture of tetrameric type IV and antibody represent specific antibody-type IV collagen complexes.
From examination of multiple micrographs, it was apparent that the binding of antibody to type IV collagen occurs with high frequency at a restricted location with respect to the 7S crosslinking region. In order to examine this specificity in detail, a number of electron micrographs of antigen-antibody complexes were selected in which the length of the 7 S domain could be accurately measured. By using this length as an internal standard for each molecule (30 nm), the antibody-binding site was determined as the distance from the end of the 7S domain to the midpoint of the antibody. A frequency-distribution histogram is depicted in Fig. 2 . Approx. 75% of the total observed binding occurs between 45 and 63 nm from the 7 S region in a roughly bimodal distribution. lOr Multiple instances of binding of more than one antibody molecule to a single type IV 'spider' are observed, and representative examples are illustrated in Fig. 1 . Two patterns of multiple binding are observed. Frequently, two antibody molecules bind to adjacent arms of a 'spider', or in a cis or trans configuration with respect to the 7S region, or both. The second pattern was the apparent 'cross-linking' of adjacent arms of a 'spider' by a single antibody molecule, an expected result of the binding of bivalent antibody to adjacent epitopes. Fig. 3(a) shows the disc-gel-electrophoresis pattern of the cysteine-containing CNBr-cleavage fragment before and after reduction. Before reduction the fragment has an M, of approx. 90000. After reduction, two major peptides, CBI and CBI-2, are visible that have M, values of approx.
35000 and 50000 respectively. Additional peptides, not yet characterized but presumably originating from the a2(IV) chain, can also be seen. Sequence analysis of peptides CB1 and CB1-2 revealed the same N-terminal amino acid sequence . Thus the larger peptide is a double peptide produced by the incomplete cleavage of methionine residues in the unreduced starting material. The intact 90000-M, fragment had a c.d. spectrum characteristic of collagen and was visible, after rotary-shadowing in the electron microscope, as about 50nm-long rods, indicating an intact triple-helical conformation . Frequency-distribution histogram relating the observed frequency oJ binding of monoclonal antibody to the distance (in nm)from the 7S cross-linking domain oftype IV collagen Note that 76% of the observed binding occurs between 45 and 63nm from this region; no binding was observed to the distal half of the arms of tetrameric type IV collagen. Inhibitor (ug) Fig. 4 . Inhibition oJ the binding oJ monoclonal antibody to natite polymeric type IV collagen Inhibitors were mixed in various amounts with a fixed dilution of monoclonal antibody and incubated overnight before assay on microtitre plates coated with native polymeric type IV collagen.
Inhibitors: 0, native, and 0, denatured polymeric type IV collagen; A, the trimeric CNBr-cleavage peptide; El and *, isolated constituent peptides CB1 (EO) and CB1-2 (U).
The CNBr digests of the al(IV)140K and acl (IV)95K peptic-digest fragments (Fig. 3b ) demonstrate the presence of peptides CB1 and CB1-2 in the cl(IV)140K digest, but not in that of al(IV)95K. The remaining peptide pattern is similar, indicating that the al(IV)95K is a fragment of al(IV)140K, in agreement with previous reports (Dixit & Kang, 1979 ). E.l.i.s.a. assays demonstrate that the small cysteine-containing CNBr-cleavage peptide binds the monoclonal antibody (results not shown). Inhibition assays indicate that the binding of antibody to polymeric type IV collagen could be blocked by prior incubation of antibody with the trimeric CNBr-cleavage fragment (Fig. 4) . The observed inhibition is as complete as that of tetrameric type IV collagen, indicating complete immunological identity. On a molar basis the magnitude of inhibitory activity of the peptide was not as high as that of the tetrameric type IV collagen, which may relate to slight modifications of the antigenic site(s) during preparation, isolation and purification procedures.
Discussion
We have demonstrated the specific binding of a monoclonal antibody to native tetramers of human type IV collagen with sufficient affinity such that antigen-antibody complexes are observable by rotary-shadowing techniques. The observed interaction of monoclonal antibody with tetrameric type IV collagen is such that 75% of total binding was observed between 45 and 63nm from the 7S region. Notably, no binding was observed to the distal half of the tetramer arms. Under the assumption of a single epitope, these data indicate a location of 55 +6nm (S.D.) from the 7S region.
Available data supports the conclusion that type IV collagen molecules are heteropolymers consisting of two a 1 (IV) and one a2(IV) chains (Trueb et al., 1982; Qian & Glanville, 1984) , and previous studies employing the monoclonal antibody used for the present study have demonstrated immunoprecipitation of newly synthesized human type IV collagen containing al(IV) and a2(IV) in a 2:1 ratio . If type IV collagen tetramers are the result of the interaction of identical heteropolymeric molecules, it then follows that localization of specific antibody-binding sites with respect to the 7S region will yield useful structural information concerning the parallel or antiparallel organization of the four collagen molecules within that domain. The observed symmetric binding of antibody to equidistant sites on the arms of type IV tetramers and the observed 'cross-linking' of adjacent arms of the tetramer are consistent only with the latter possibility. This is in agreement with data on the binding of monoclonal antibody to both human (Foellmer et al., 1983) and chicken (Mayne et al., 1984) type IV collagen tetramers. The antibody-binding data, together with biosynthetic (Fessler & Fessler, 1982; Oberbaumer et al., 1982) and structural studies (Weber et al., 1984; Babel & Glanville, 1984; Qian & Glanville, 1984) , confirms the antiparallel alignment of the type IV collagen molecules in the tetramer.
Since the CNBr-cleavage-derived triple-helical peptide described here contains the relevant antigenic binding site(s) for the monoclonal antibody, this peptide must be localized to the antibody-binding region of the type IV molecule about 55 nm from the 7S domain. Therefore this region must also contain intramolecular disulphide bridges. This particular area of the collagen molecule appears to be highly immunogenic, since two other monoclonal antibodies directed against peptic-digest-derived human and chick type IV collagen respectively were found to bind there (Foellmer et al., 1983; Mayne et al., 1984) . The reason for this high antigenicity may be the presence of two special structural features in this region. Firstly, as demonstrated in the present paper, this region contains intramolecular disulphide bridges that cross-link the three a-chains of the molecule. Steric considerations suggest that such bridges must occur in discontinuities of the helix, but the absence of alterations in the threadlike profiles observed by rotary shadowing suggests that such discontinuities are small. Secondly, it Vol. 227 exhibits a particularly high flexibility, which is presumably caused by an accumulation of nontriple-helical regions (Hofmann et al., 1984) . The disulphide bridges appear to protect this region from proteolysis by pepsin. The large peptic-digest fragment, al(IV)140K, contains the CNBr-cleavage peptide CB1. Reduction of this large fragment followed by further pepsin treatment yields a fragment, a l(IV)95K, that no longer contains peptide CB1. This also indicated that peptide CB1 is located at the N-or the C-terminus of a l(IV)95. As the axl(IV)140K fragment contains both al(IV)95K and peptide CBI, and peptide CB1 is located 55nm from the 7S domain, then peptide CBl must be located at the N-terminus of the al(IV)140K fragment. The localization of the helical disulphidebridged 90000-Mr CNBr-cleavage fragment, which contains peptide CB1, therefore permitted the alignment of both the 140000-Mr and the 95000-Mr a l(IV) peptic-digest fragments (Fig. 5) . A comparison of the flexibility profiles of the 330nm-long and 267nm-long triple-helical fragments with that of the intact molecule has also suggested that the two fragments terminate at or near the C-terminus of the triple helix of the molecule (Hofmann et al., 1984) . In confirmation, sequence studies have shown that the C-terminal end of the a 1(IV)95K fragment carries a short noncollagenous amino acid sequence that is part of the C-terminal globular domain of the al(IV) chain (Weber et al., 1984; Babel & Glanville, 1984) .
